HEMP news Hemp, Inc. (OTC: HEMP) Forms Alliance
Post# of 144503
HEMP news
Hemp, Inc. (OTC: HEMP) Forms Alliance with The Art of Mary Jane Magazine to Private Label the HerbaGenix™ Products MJ Lover for Him™ and MJ Lover for Her™
2012-10-04 07:55 ET - News Release
LAS VEGAS , Oct. 4, 2012 /PRNewswire/ -- HEMP, INC. (OTC: HEMP) ( www.hemp.com ), a publicly traded company forging a path in the industrial hemp industry, while educating consumers on the myriad of uses for industrial hemp agrees on collaboration with world renowned international magazine, The Art of Mary Jane , currently in over 10 countries and expanding. The mass exposure of the HerbaGenix™ hemp nutraceuticals, specifically Mary Jane Lover (MJ Lover) will inevitably put MJ Lover in retail outlets in all 50 states and distributed in international markets. Hemp, Inc. (OTC: HEMP) is the manufacturer of the all-natural HerbaGenix™ line ( www.herbagenix.com ) that contains hemp extracts proven to increase the body's overall health and performance. Typically, genetically modified and processed foods wreak havoc on the human body, breaking down the body's immune system. MJ Lover, however, will help rebuild and repair the immune system to above normal levels, while promoting not only sexual health, but an overall well-being. MJ Lover, a product of Hemp, Inc.'s HerbaGenix™ product line has been derived from a blend of organic nutrients, herbs, and vitamins including hemp extract (0.00% THC) and AFA blue-green algae which is known for its healthful effects. The product is cGMP compliant to FDA standards and is scientifically proven to promote health and give a natural energy boost. Through The Art of Mary Jane Magazine, MJ Lover will be promoting a special introductory offer to medical marijuana dispensaries throughout the United States . All dispensaries interested in carrying MJ Lover should call 1-866-366-4694 or for info email sales@mjlover.com ( www.mjlover.com ). The hemp and hemp extracts, along with effective antioxidants, in MJ Lover will provide patients a safe alternative to high risk commercial medicines.